chr17-50568250-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_018896.5(CACNA1G):​c.243-620G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0722 in 152,012 control chromosomes in the GnomAD database, including 487 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.072 ( 487 hom., cov: 32)

Consequence

CACNA1G
NM_018896.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.580

Publications

10 publications found
Variant links:
Genes affected
CACNA1G (HGNC:1394): (calcium voltage-gated channel subunit alpha1 G) Voltage-sensitive calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division, and cell death. This gene encodes a T-type, low-voltage activated calcium channel. The T-type channels generate currents that are both transient, owing to fast inactivation, and tiny, owing to small conductance. T-type channels are thought to be involved in pacemaker activity, low-threshold calcium spikes, neuronal oscillations and resonance, and rebound burst firing. Many alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Sep 2011]
CACNA1G Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Illumina, PanelApp Australia, Ambry Genetics
  • spinocerebellar ataxia type 42
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Illumina
  • intellectual disability
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0917 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018896.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1G
NM_018896.5
MANE Select
c.243-620G>T
intron
N/ANP_061496.2
CACNA1G
NM_198377.3
c.243-620G>T
intron
N/ANP_938191.2
CACNA1G
NM_198396.3
c.243-620G>T
intron
N/ANP_938406.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1G
ENST00000359106.10
TSL:1 MANE Select
c.243-620G>T
intron
N/AENSP00000352011.5
CACNA1G
ENST00000507336.5
TSL:1
c.243-620G>T
intron
N/AENSP00000420918.1
CACNA1G
ENST00000507510.6
TSL:1
c.243-620G>T
intron
N/AENSP00000423112.2

Frequencies

GnomAD3 genomes
AF:
0.0720
AC:
10936
AN:
151894
Hom.:
474
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0943
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.0725
Gnomad ASJ
AF:
0.115
Gnomad EAS
AF:
0.0300
Gnomad SAS
AF:
0.0436
Gnomad FIN
AF:
0.0749
Gnomad MID
AF:
0.0538
Gnomad NFE
AF:
0.0618
Gnomad OTH
AF:
0.0699
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0722
AC:
10970
AN:
152012
Hom.:
487
Cov.:
32
AF XY:
0.0713
AC XY:
5301
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.0942
AC:
3902
AN:
41436
American (AMR)
AF:
0.0726
AC:
1109
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.115
AC:
398
AN:
3466
East Asian (EAS)
AF:
0.0301
AC:
155
AN:
5148
South Asian (SAS)
AF:
0.0439
AC:
211
AN:
4810
European-Finnish (FIN)
AF:
0.0749
AC:
794
AN:
10594
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.0618
AC:
4202
AN:
67964
Other (OTH)
AF:
0.0810
AC:
171
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
505
1011
1516
2022
2527
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0600
Hom.:
235
Bravo
AF:
0.0731
Asia WGS
AF:
0.0880
AC:
307
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
4.6
DANN
Benign
0.60
PhyloP100
0.58
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs198545; hg19: chr17-48645611; API